- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02493556
Effect of Low-level Laser Therapy on Exercise-induced Muscle Damage
Effect of Low-level Laser Therapy on Exercise-induced Muscle Damage: a Randomized Clinical Trial
Introduction: The effects of Low Level Laser Therapy (LLLT) on exercise-induced muscular damage have been studied over the last years. Studies have been conducted on animals and humans in order to try to show the benefits of the intervention, but there is still conflicting evidence about its protective and therapeutic effects.
Objectives: To describe the effects of LLLT on pain, strength and muscular inflammation after plyometric exercise.
Methods: A randomized, double-blinded, placebo-controlled trial with participation of 20 male healthy volunteers will be performed. Healthy and physically active individuals, aged between 18 and 35 years, with no history of injury on the lower limbs or contra-indications to maximal exercise performance will be included. A protocol of 10 series with 10 repetitions of the countermovement jump will be used to induce muscle damage at the lower limbs. Immediately before or after the exercise protocol, LLLT will be applied on one lower limb, while the other will receive placebo treatment. Phototherapy will be applied with an equipment of 810nm and a cluster with 5 diodes on 8 different points of the knee extensor muscle, totalizing a dosage of 240J. The placebo treatment will be held on the same way, but the equipment will be turned off. The volunteers will be evaluated at baseline (before the exercise protocol) and at follow-up of 24, 48 and 72 hours. The following outcomes will be evaluated: knee extensors isometric peak torque by Isokinetic Dynamometer, pain by Visual Analogue Scale and muscular tissue echo intensity by Ultrasonography.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
RS
-
Porto Alegre, RS, Brésil, 90050-170
- Federal University of Health Science of Porto Alegre
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Healthy males aged between 18 and 35 years;
- Sedentary or physically active individuals who exercise up to 3 times per week.
Exclusion Criteria:
- Individuals who participate in systematic exercise training;
- Individuals who participate in strength training for the lower limbs;
- Individuals with lower or upper limb injuries;
- Individuals with contra-indications to maximal exercise performance (due to neurological, cardiovascular or respiratory conditions);
- Individuals who show difficulties to understand the study protocol.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: LLLT before muscle damage
Low Level Laser Therapy (LLLT) will be applied before the exercise protocol on one lower limb, while the other will receive placebo treatment.
Phototherapy will be applied with an equipment of 810nm and a cluster with five diodes on eight different points of quadriceps muscle, totalizing a dosage of 240J.
|
|
|
Comparateur placebo: Placebo LLLT before muscle damage
Placebo LLLT will be applied before the exercise protocol on one lower limb, while the other will receive real treatment.
Placebo treatment will also be applied on eight different points of quadriceps muscle, but the equipment will be turned off.
|
|
|
Comparateur actif: LLLT after muscle damage
Low Level Laser Therapy (LLLT) will be applied after the exercise protocol on one lower limb, while the other will receive placebo treatment.
Phototherapy will be applied with an equipment of 810nm and a cluster with five diodes on eight different points of quadriceps muscle, totalizing a dosage of 240J.
|
|
|
Comparateur placebo: Placebo LLLT after muscle damage
Placebo LLLT will be applied after the exercise protocol on one lower limb, while the other will receive real treatment.
Placebo treatment will also be applied on eight different points of quadriceps muscle, but the equipment will be turned off.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Knee extensors isometric peak torque (Nm)
Délai: Baseline and 24, 48 and 72 hours follow-up
|
Isokinetic Dynamometer
|
Baseline and 24, 48 and 72 hours follow-up
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Knee extensors soreness (Visual Analogue scale)
Délai: Baseline and 24, 48 and 72 hours follow-up
|
Baseline and 24, 48 and 72 hours follow-up
|
|
Knee extensors echo intensity (number of white and black pixels)
Délai: Baseline and 24, 48 and 72 hours follow-up
|
Baseline and 24, 48 and 72 hours follow-up
|
Collaborateurs et enquêteurs
Les enquêteurs
- Directeur d'études: Bruno Baroni, phD, Federal University of Health Science of Porto Alegre
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 38076514.0.0000.5345
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .